From: Role of days postdelivery on breast milk production: a secondary analysis from the EMPOWER trial
Characteristic | 8–14 days postdelivery N = 44 | 15–21 days postdelivery N = 46 | p - value |
---|---|---|---|
Maternal age (years) (SD) (range) | 32.1 (5.7) | 30.7 (6.1) | 0.29 |
(19.7, 40.9) | (19.4, 44.6) | ||
Self-declared ethnicity, n (%) | |||
Caucasian | 29 (65.9%) | 30 (65.2%) | 0.14 |
Black | 2 (4.5%) | 8 (17.4%) | |
Asian | 10 (22.7%) | 6 (13.1%) | |
Aboriginal | 0 (0%) | 1 (2.2%) | |
Other | 3 (6.8%) | 1 (2.2%) | |
Smoking prior to pregnancy, n (%) | 16 (36.4%) | 12 (26.7%) | 0.33 |
Primigravida, n (%) | 17 (38.6%) | 14 (30.4%) | 0.41 |
Comorbidities, n (%) | 20 (45.0%) | 26 (57.0%) | 0.29 |
Hypertension Gestational/chronic) | 4 | 8 | |
Diabetes (Gestational/Type I and II) | 5 | 3 | |
Preterm Labour | 5 | 7 | |
Chorioamnionitis | 1 | 2 | |
Antepartum haemorrhage | 7 | 3 | |
Other | 9 | 9 | |
Antenatal corticosteroids, n (%) | 40 (90.9%) | 36 (78.3%) | 0.09 |
Cesarean delivery, n (%) | 24 (54.5%) | 24 (52.2%) | 0.82 |
Singleton Pregnancy, n (%) | 37 (84.1%) | 40 (86.9%) | 0.77 |
Gestational age at delivery, mean (SD) | 27.4 (1.7) | 26.83 (1.6) | 0.11 |
Infant weight at trial entry, mean (SD) | 1016 (259) | 906 (229) | 0.03 |